Monica E Bianco1,2, Jami L Josefson3,4. 1. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. 2. Division of Endocrinology, Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E. Chicago Avenue, Box 54, Chicago, IL, 60611, USA. 3. Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. J-Josefson@northwestern.edu. 4. Division of Endocrinology, Ann & Robert H. Lurie Children's Hospital of Chicago, 225 E. Chicago Avenue, Box 54, Chicago, IL, 60611, USA. J-Josefson@northwestern.edu.
Abstract
PURPOSE OF REVIEW: This review will focus on the long-term outcomes in offspring exposed to in utero hyperglycemia and gestational diabetes (GDM), including obesity, adiposity, glucose metabolism, hypertension, hyperlipidemia, nonalcoholic fatty liver disease, and puberty. RECENT FINDINGS: There is evidence, mostly from observational studies, that offspring of GDM mothers have increased risk of obesity, increased adiposity, disorders of glucose metabolism (insulin resistance and type 2 diabetes), and hypertension. In contrast, evidence from the two intervention studies of treatment of mild GDM and childhood measures of BMI, adiposity, and glucose tolerance do not demonstrate that GDM treatment significantly reduces adverse childhood metabolic outcomes. Thus, more evidence is needed to understand the impact of maternal GDM on offspring's adiposity, glucose metabolism, lipid metabolism, risk of fatty liver disease, and pubertal onset. Offspring of GDM mothers may have increased risk for metabolic and cardiovascular complications. Targeting this group for intervention studies to prevent obesity and disorders of glucose metabolism is one potential strategy to prevent adverse metabolic health outcomes.
PURPOSE OF REVIEW: This review will focus on the long-term outcomes in offspring exposed to in utero hyperglycemia and gestational diabetes (GDM), including obesity, adiposity, glucose metabolism, hypertension, hyperlipidemia, nonalcoholic fatty liver disease, and puberty. RECENT FINDINGS: There is evidence, mostly from observational studies, that offspring of GDM mothers have increased risk of obesity, increased adiposity, disorders of glucose metabolism (insulin resistance and type 2 diabetes), and hypertension. In contrast, evidence from the two intervention studies of treatment of mild GDM and childhood measures of BMI, adiposity, and glucose tolerance do not demonstrate that GDM treatment significantly reduces adverse childhood metabolic outcomes. Thus, more evidence is needed to understand the impact of maternal GDM on offspring's adiposity, glucose metabolism, lipid metabolism, risk of fatty liver disease, and pubertal onset. Offspring of GDM mothers may have increased risk for metabolic and cardiovascular complications. Targeting this group for intervention studies to prevent obesity and disorders of glucose metabolism is one potential strategy to prevent adverse metabolic health outcomes.
Entities:
Keywords:
Childhood metabolic disease; Developmental programming of diabetes; Exposure to gestational diabetes mellitus; Gestational diabetes treatment effect on offspring; Long-term offspring outcomes; Pregnancy
Authors: Caroline A Crowther; Janet E Hiller; John R Moss; Andrew J McPhee; William S Jeffries; Jeffrey S Robinson Journal: N Engl J Med Date: 2005-06-12 Impact factor: 91.245
Authors: T L Crume; L Ogden; N A West; K S Vehik; A Scherzinger; S Daniels; R McDuffie; K Bischoff; R F Hamman; J M Norris; D Dabelea Journal: Diabetologia Date: 2010-10-17 Impact factor: 10.122
Authors: Maicon Falavigna; Maria I Schmidt; Janet Trujillo; Luísia F Alves; Eliana R Wendland; Maria R Torloni; Stephen Colagiuri; Bruce B Duncan Journal: Diabetes Res Clin Pract Date: 2012-09-29 Impact factor: 5.602
Authors: Lea L B Lauridsen; Linn H Arendt; Andreas Ernst; Nis Brix; Erik T Parner; Jørn Olsen; Cecilia H Ramlau-Hansen Journal: Fertil Steril Date: 2018-06-13 Impact factor: 7.329
Authors: Matthew W Gillman; Helena Oakey; Peter A Baghurst; Robert E Volkmer; Jeffrey S Robinson; Caroline A Crowther Journal: Diabetes Care Date: 2010-02-11 Impact factor: 19.112